**Core Concept:** In pediatric patients, calculating an appropriate dose of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) requires considering their body surface area (BSA) and weight. The most important factor for dose adjustment is the patient's body weight, as it directly influences the drug's pharmacokinetics and pharmacodynamics.

**Why the Correct Answer is Right:** Body weight ensures an approximate dosage for the child, considering that the drug's concentration in plasma is directly proportional to the patient's body weight. Adequate drug concentration is crucial for therapeutic effects while minimizing the risk of side effects and toxicity.

**Why Each Wrong Option is Incorrect:**

A. **Body Surface Area (BSA)** is an important factor in pediatric drug dosing but is not the most important factor. While BSA contributes to the volume of distribution, body weight remains the primary determinant of drug concentration in plasma.

B. **Age and Development**: Although age influences the child's organ development, body weight remains more significant in ensuring adequate drug concentration in plasma.

C. **Surface Area**: Surface area does not directly correlate with drug distribution and plasma concentration. Body weight is more crucial for ensuring appropriate drug exposure.

D. **Dosage Form**: The choice of dosage form (e.g., oral, IV) influences the absorption but does not change the importance of body weight in determining drug concentration in plasma.

**Clinical Pearl:** To avoid toxicity and ensure efficacy, weight-based dosing is essential for pediatric patients, particularly for NSAIDs. Underdosing may lead to inadequate therapeutic effects, while overdosing increases the risk of adverse effects, such as renal impairment and gastrointestinal complications.

**Correct Answer:** D. Surface Area